Matchpoint Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 33

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $70M

  • Investors
  • 7

Matchpoint Therapeutics General Information

Description

Developer of precision small molecule medicines intended to harness the power of covalency to transform the treatment of immune diseases. The company's advanced covalent exploration platform integrates advanced chemo proteomics, machine learning, and covalent chemistry library evolution, enabling medical professionals to probe deeper into the proteome to identify and scan new binding sites on disease-causing proteins.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • One Kendall Square
  • Building 400 Suite 201
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Artificial Intelligence & Machine Learning, HealthTech, Life Sciences
Corporate Office
  • One Kendall Square
  • Building 400 Suite 201
  • Cambridge, MA 02139
  • United States
+1 (617)

Matchpoint Therapeutics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Matchpoint Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series A) 14-Oct-2022 $70M Completed Generating Revenue
1. Seed Round 01-Nov-2021 Completed Generating Revenue
To view Matchpoint Therapeutics’s complete valuation and funding history, request access »

Matchpoint Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
Seed
To view Matchpoint Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Matchpoint Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Matchpoint Therapeutics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Alexandria Venture Investments Venture Capital Minority
Digitalis Ventures Venture Capital Minority
Sanofi Ventures Corporate Venture Capital Minority
Vertex Ventures HC Venture Capital Minority
Access Biotechnology Corporate Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Matchpoint Therapeutics FAQs

  • When was Matchpoint Therapeutics founded?

    Matchpoint Therapeutics was founded in 2021.

  • Where is Matchpoint Therapeutics headquartered?

    Matchpoint Therapeutics is headquartered in Cambridge, MA.

  • What is the size of Matchpoint Therapeutics?

    Matchpoint Therapeutics has 33 total employees.

  • What industry is Matchpoint Therapeutics in?

    Matchpoint Therapeutics’s primary industry is Drug Discovery.

  • Is Matchpoint Therapeutics a private or public company?

    Matchpoint Therapeutics is a Private company.

  • What is the current valuation of Matchpoint Therapeutics?

    The current valuation of Matchpoint Therapeutics is .

  • What is Matchpoint Therapeutics’s current revenue?

    The current revenue for Matchpoint Therapeutics is .

  • How much funding has Matchpoint Therapeutics raised over time?

    Matchpoint Therapeutics has raised $100M.

  • Who are Matchpoint Therapeutics’s investors?

    Alexandria Venture Investments, Digitalis Ventures, Sanofi Ventures, Vertex Ventures HC, and Access Biotechnology are 5 of 7 investors who have invested in Matchpoint Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »